Cordis News
Most Popular Cordis Story
J&J revenue sees first decline in 76 years
While overall earnings were ahead of what analysts predicted for drugmaker Johnson & Johnson, it is clear that generic competition has hurt the company's sales. The company earned $2.6 billion Read more...
Latest Headlines
- June 16, 2011
- March 9, 2011
- January 21, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
